Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16949731rdf:typepubmed:Citationlld:pubmed
pubmed-article:16949731lifeskim:mentionsumls-concept:C0007134lld:lifeskim
pubmed-article:16949731lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16949731lifeskim:mentionsumls-concept:C2362057lld:lifeskim
pubmed-article:16949731lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:16949731lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16949731lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16949731pubmed:issue3lld:pubmed
pubmed-article:16949731pubmed:dateCreated2007-1-22lld:pubmed
pubmed-article:16949731pubmed:abstractTextThe tumour suppressor gene p16INK4a is a cyclin-dependent kinase inhibitor, for which inactivation attributable to promoter hypermethylation or homozygous deletion has been described in malignancies. Little is known about p16INK4a protein levels in renal cell carcinoma (RCC) and its association with clinicopathologic parameters or disease progression.lld:pubmed
pubmed-article:16949731pubmed:languageenglld:pubmed
pubmed-article:16949731pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16949731pubmed:citationSubsetIMlld:pubmed
pubmed-article:16949731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16949731pubmed:statusMEDLINElld:pubmed
pubmed-article:16949731pubmed:monthMarlld:pubmed
pubmed-article:16949731pubmed:issn0302-2838lld:pubmed
pubmed-article:16949731pubmed:authorpubmed-author:JonasUdoUlld:pubmed
pubmed-article:16949731pubmed:authorpubmed-author:von...lld:pubmed
pubmed-article:16949731pubmed:authorpubmed-author:MachtensStefa...lld:pubmed
pubmed-article:16949731pubmed:authorpubmed-author:KuczykMarkus...lld:pubmed
pubmed-article:16949731pubmed:authorpubmed-author:ShittuOlayiwo...lld:pubmed
pubmed-article:16949731pubmed:authorpubmed-author:IkuerowoSteph...lld:pubmed
pubmed-article:16949731pubmed:authorpubmed-author:SerthJürgenJlld:pubmed
pubmed-article:16949731pubmed:issnTypePrintlld:pubmed
pubmed-article:16949731pubmed:volume51lld:pubmed
pubmed-article:16949731pubmed:ownerNLMlld:pubmed
pubmed-article:16949731pubmed:authorsCompleteYlld:pubmed
pubmed-article:16949731pubmed:pagination732-7; discussion 738lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:meshHeadingpubmed-meshheading:16949731...lld:pubmed
pubmed-article:16949731pubmed:year2007lld:pubmed
pubmed-article:16949731pubmed:articleTitlep16INK4a expression and clinicopathologic parameters in renal cell carcinoma.lld:pubmed
pubmed-article:16949731pubmed:affiliationDepartment of Urology, Medizinische Hochschule Hannover, Hannover, Germany.lld:pubmed
pubmed-article:16949731pubmed:publicationTypeJournal Articlelld:pubmed